News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Match Group bakes Tinder recovery and Hinge growth into guidance, supporting further upside for MTCH despite the recent rally.
  • PTC appears undervalued with strong free cash flow and mid-teens multiple re-rating potential from AI and digital twin expansion.
  • Teladoc offers cheap cash-flow metrics and an outcomes-based integrated care product that could drive higher-margin revenue.
  • Marvell is positioned as a leveraged AI infrastructure play via data-center exposure and Nvidia ties, supporting a long-trade thesis.
  • Viavi's revenue and profit acceleration with bullish guidance sets up a mid-term swing trade tied to optical networking demand.

Latest Articles

Cheap, Cash-Generative, and Under Pressure: A Tactical Long on AMCX

Cheap, Cash-Generative, and Under Pressure: A Tactical Long on AMCX

AMC Global Media (AMCX) looks actionable on a mid-term swing: the company reported accelerating streaming revenue, generated meaningful free cash flow, and completed debt exchanges that create room for up to $50M of buybacks. Valuation is compressed (market cap roughly $470M; P/FCF ~2.6) and technical momentum is constructive. This trade idea targe…

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Ascentage Pharma, a global biopharmaceutical company focused on cancer therapies, will release its unaudited six-month interim results for 2026 on August 19, 2026. The company will host investor webcasts in English and Mandarin, providing updates on its drug pipeline, ongoing Phase III clinical trials, and partnerships with key industry players. Th…

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC reported strong financial results for the three and six months ended June 30, 2026. The company posted an 8% increase in quarterly net income to $11.1 million, driven by a favorable loss ratio of 53.8%. Belmont Core segment gross written premiums grew by 7% in Q2. For the six months, net income surged to $15.3 million fr…

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Damora Therapeutics announced the initiation of the global Phase 1/1b CLARITY-101 clinical trial to evaluate DMR-001, a novel monoclonal antibody designed to target mutant calreticulin (mutCALR) in patients with essential thrombocythemia and myelofibrosis. Preclinical data showed DMR-001 has significantly higher binding potency and longer half-life…

High Roller Technologies Schedules Conference Call to Provide a Business Update and Discuss Second Quarter 2026 Financial Results

High Roller Technologies Schedules Conference Call to Provide a Business Update and Discuss Second Quarter 2026 Financial Results

High Roller Technologies, a publicly traded company on NYSE (ticker: ROLR) specializing in online gaming and prediction markets, announced a conference call on August 11, 2026, to discuss its Q2 financial results and provide a business update. Management will also highlight strategic initiatives, including a planned launch of prediction markets. Th…

ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio announced its financial results for Q2 2026 alongside clinical progress for its lead candidate, olevaprubart, a differentiated anti-OX40 monoclonal antibody targeting immunological diseases such as atopic dermatitis and alopecia areata. The Phase 2b trial in moderate-to-severe atopic dermatitis is advancing as planned with an amended pro…

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Lifeward Ltd. has launched a six-month pilot program with Ottobock Care to increase patient access to the ReWalk® 7 Personal Exoskeleton across the U.S. The partnership leverages Ottobock Care's clinical expertise and nationwide clinic network to enhance patient evaluation, training, and follow-up, aiming to scale ReWalk's commercial reach and acce…

CoreCivic Sells Two Additional Detention Facilities

CoreCivic Sells Two Additional Detention Facilities

CoreCivic has sold its Prairie Correctional Facility and Midwest Regional Reception Center to the U.S. Department of Homeland Security for a combined gross price of $734 million. After taxes and transaction costs, net proceeds are expected to be approximately $522.5 million, which the company plans to use for general corporate purposes such as debt…

YETI Holdings, Inc. Announces Investor Day on September 17, 2026

YETI Holdings, Inc. Announces Investor Day on September 17, 2026

YETI Holdings, Inc. announced it will hold an Investor Day on September 17, 2026, in Austin, Texas. The event will feature presentations from the leadership team discussing the company's long-term strategy. It will be accessible both in-person and via a live webcast through the company's investor relations website. The company is known for its inno…

Safe Harbor Financial Series B Preferred Conversion Price and Warrant Exercise Price Reset to $1.5528 Following Conclusion of Temporary Reduction Period

Safe Harbor Financial Series B Preferred Conversion Price and Warrant Exercise Price Reset to $1.5528 Following Conclusion of Temporary Reduction Period

Safe Harbor Financial announced the end of the temporary reduction period for its Series B Convertible Preferred Stock conversion price and associated warrant exercise price, both reverting to $1.5528. During the reduction period, significant conversions of preferred stock into common stock occurred, simplifying the company's capital structure and …

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Jupiter Neurosciences, Inc., a clinical-stage biopharmaceutical company, announced a 1-for-75 reverse stock split effective August 6, 2026, aimed at increasing the share price to regain compliance with Nasdaq's minimum bid price requirements. The stock will trade on a post-split basis from August 7, 2026, under the ticker JUNS. The reverse split wi…

Global Ship Lease Reports Results for the Second Quarter of 2026

Global Ship Lease Reports Results for the Second Quarter of 2026

Global Ship Lease reported solid operating results for Q2 2026, including $198.7 million in operating revenue and $89.3 million in net income available to common shareholders. The company announced an order for 15 modern mid-size containerships valued at $1.33 billion, with multi-year charters secured, enhancing future earnings visibility. Contract…

Karat Packaging Board Increases Quarterly Cash Dividend

Karat Packaging Board Increases Quarterly Cash Dividend

Karat Packaging Inc., a U.S.-based manufacturer and distributor of disposable foodservice products, announced a 4.4% increase in its quarterly cash dividend to $0.47 per share, payable August 28, 2026. This dividend hike reflects the company's strong financial position and shareholder returns focus.

One Stop Systems Reports Q2 2026 Results

One Stop Systems Reports Q2 2026 Results

One Stop Systems reported a 62.3% year-over-year increase in Q2 2026 revenue to $9.3 million and recorded its highest quarterly bookings of $15.1 million, reflecting strong demand in rugged enterprise-class edge computing solutions. Driven by diverse defense and commercial customers, including a significant U.S. Department of Defense contract, the …

Terra Innovatum Added to Solactive Global Uranium & Nuclear Components Total Return Index, the Benchmark Tracked by the Global X Uranium ETF (URA)

Terra Innovatum Added to Solactive Global Uranium & Nuclear Components Total Return Index, the Benchmark Tracked by the Global X Uranium ETF (URA)

Terra Innovatum Global N.V., a Nasdaq-listed micro-modular reactor developer, has been added to the Solactive Global Uranium & Nuclear Components Total Return Index, the benchmark tracked by the Global X Uranium ETF (URA). This inclusion expands Terra Innovatum’s visibility to institutional and passive investors seeking exposure to the uranium and …

Elanco Shares Leap After Q2 Results Beat Expectations, Guidance Raised

Elanco Shares Leap After Q2 Results Beat Expectations, Guidance Raised

Elanco Animal Health rallied in pre-market trading after reporting second-quarter 2026 results that outpaced analyst expectations across key metrics and prompted management to lift its full-year outlook. The company posted adjusted EPS of $0.34 versus consensus of $0.27 and revenue of $1.37 billion against estimates of $1.31 billion, with robust co…

Citadel’s Big Funds Record July Gains as AI-Fueled Tech Selloff Hits Peers

Citadel’s Big Funds Record July Gains as AI-Fueled Tech Selloff Hits Peers

Citadel’s three large funds delivered solid gains in July even as a sector-wide technology selloff linked to concerns about AI spending inflicted losses on many hedge funds. The firm’s Wellington fund rose 6% in July (up 12% year-to-date), its tactical trading arm gained 11% in July (up 27% YTD) and its stock-focused equities fund increased 14.2% f…